Adopt AI, accelerate development and increase velocity. With 84% of respondents to the Stack Overflow 2025 Developer Survey ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

The developers behind Arverne East, NYC's first net-zero community in Far Rockaway, secured $278.8 million for its first ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Statewide paid family and medical leave (PFML) programs deliver essential benefits to individuals who need time away from ...

GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

Several major development projects across Flint are expected to advance or reach key milestones in 2026, ranging from ...

The new contract covers the Post-Critical Design Review phase of the B-52 Commercial Engine Replacement Program, which will replace the TF33 engines with ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...